Biotechnology and cellular-agriculture companies need scalable tissue-engineering platforms and growth-media capabilities to commercialise cultivated products.
R&D Focus
Tissue engineering, cellular agriculture and biotech investment through subsidiary companies.
Innovative Solution
Operates as a listed biotech group developing and acquiring technologies across tissue engineering and cultivated products.
Investment Funding
Last Funding Stage
Post-IPO Equity
Total Funding Amount
682.74K
Last Funding Amount
635.04K
Last Funding Date
04-12-2024
Startup Stage
IPO
Lead Investors
Innovate UK
Revenue
$1M to $10M
People
Founders
Geoff Baker
About
BSF Enterprise (LON:BSFA) is unlocking the next generation of biotech solutions through an acquisition-led growth strategy to drive the development of lab-grown tissues. Cell-based tissue engineering can be used to generate cultured meat, lab-grown leather, human corneas, collagen growth and skin substitutes. This technology will contribute to a radical transformation of the delivery of sustainable solutions across a variety of sectors.
Products
Product
Unlocking the next generation of biotech solutions.
Demo Product or Complete Product?
Corporate biotech platform; product maturity depends on individual subsidiaries and programmes.
Something missing or incorrect on this page? Help us enrich this information
